期刊名称：FEBS OPEN BIO
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
As of January 2016, both FEBS Open Bio and FEBS Letters will join their sister journal, The FEBS Journal, and start publishing with Wiley.
Overview
FEBS Open Bio is an online-only open access journal for the rapid publication of research articles in molecular and cellular life sciences in both health and disease. The journal's peer review process focuses on the technical soundness of papers, leaving the assessment of their impact and importance to the scientific community.
Aims and Scope
FEBS Open Bio publishes experimental findings, critical analysis, methodological and technical innovations, and hypotheses. Novel or innovative work is encouraged, but papers describing sound science of a confirmatory nature in developing fields or extending knowledge of an important topic from one organism to another will also be considered.
Articles originally submitted to other FEBS publications (FEBS Letters, FEBS Journal and Molecular Oncology) can be transferred for consideration by FEBS Open Bio with their original reviewer reports, without the need to resubmit or reformat the manuscript.
FEBS Open Bio offers:
- Easy online manuscript submission and tracking system
- Fast and helpful peer review - median time to first decision 20 days
- Transfer service for articles from other FEBS journals, conserving peer reviews
- Fast publication
- Accepted articles published online within 7 days
- Author-corrected final version available within 20 days
- All articles are deposited in PubMed Central and indexed in PubMed
Abstracting and Indexing Information
- BIOSIS Previews (Thomson Reuters)
- Embase (Elsevier)
- MEDLINE/PubMed (NLM)
- Science Citation Index Expanded (Thomson Reuters)
- SCOPUS (Elsevier)
- Web of Science (Thomson Reuters)
Instructions to Authors
Author Guidelines
Author guidelines for those looking to publish with FEBS Open Bio can be found in pdf format HERE
GUIDE FOR AUTHORS
Aims and Scope
Submission procedure
Open Access publication fee
Author inquiries
Policies
Ethics in publishing
Work involving human or animal subjects or tissues
Conflict of interest
Submission declaration
Role of the funding source
Open Access copyright license
Manuscript preparation
Word processing software
Article structure
Title page and Abstract
Material and methods
Results
Discussion
Conclusions
Acknowledgements
Author contribution statement
References
Tables
Figures
Supporting Information
Standards of data reporting
Database linking
Nomenclature and units
Math formulae
Suggested reviewers
Submission checklist
After acceptance
Early View
Proofs
Article publicity
Changes to authorship
FEBS Open Bio is an online-only Open Access journal for the rapid publication of research articles in molecular and cellular life sciences in both health and disease. The journal’s peer review process focuses on the technical soundness of papers, leaving the assessment of their impact and importance to the scientific community.
FEBS Open Bio is owned by the Federation of European Biochemical Societies (FEBS, http://www.febs.org), a charity whose objectives are to promote research and education in the molecular life sciences. Any income from the journal will be used to support scientists through fellowships, courses, travel grants, and other FEBS initiatives.
FEBS Open Bio publishes experimental findings, critical analysis, methodological and technical innovations, and hypotheses. Novel or innovative work is encouraged, but papers describing sound science of a confirmatory nature in developing fields or extending knowledge of an important topic from one organism to another will also be considered.
Articles originally submitted to other FEBS Press publications (FEBS Letters , The FEBS Journal and Molecular Oncology) can be transferred for consideration by FEBS Open Bio with their original reviewer reports, without the need to resubmit or reformat the manuscript.
FEBS Open Bio offers:
-
Easy online manuscript submission and tracking system
-
Fast and helpful peer review – median time to first decision 25 days in 2015
-
Transfer service for articles from other FEBS journals, conserving peer reviews
-
Fast publication
-
Accepted articles published online within 7 days (subject to receipt of signed license agreement)
-
Author-corrected final version available within 20 days (subject to receipt of Article Publication Charge)
Papers should be submitted using the FEBS Open Bio online submission system, https://mc.manuscriptcentral.com/febsopen. You will be guided stepwise through the creation and uploading of your files. The system automatically converts source files to a single PDF file of the article, which is used in the peer-review process. You are welcome to submit your manuscript as a single file to be used in the peer-review process. Only when your paper reaches final revision stage will you be requested to deliver the individual files in the correct format for publication of your article. All correspondence, including notification of the Editor's decision and requests for revision, takes place by e-mail.
FEBS Open Bio is an Open Access journal with no subscribers. A fee is payable by the author or research funder to cover the costs associated with publication. This ensures each article will be immediately and permanently free for anyone to access. The Open Access publication fee for this journal is $1350, excluding taxes. Authors will be asked to pay the article publication charge on acceptance of their article.
Your institute or funder may have an agreement with Wiley to pay all or some of the article publication charge on your behalf. You can check here. Waivers and discounts are available to authors from countries eligible for the Research4Life programs. You can check the lists of countries here.
For inquiries relating to the submission or reviewing process, please contact the Editorial Office at openbio@camfebs.co.uk. Contact details for questions arising after acceptance of an article, especially those relating to proofs, will be provided by our publishers, Wiley.
All authors are required to register for Author Services. Author Services enables authors to track their article, after acceptance, through the production process to publication online. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production. The author will receive an e-mail with a unique link that enables them to register and have their article automatically added to the system. Authors can nominate up to 10 colleagues to have complimentary access to the article once published online. Visit our Author Services site for more details on online production tracking, tips on article preparation and submission, and more.
Please ensure that a complete e-mail address is provided when submitting the manuscript. You can track accepted articles and check Wiley author FAQs at http://authorservices.wiley.com/bauthor/default.asp. Answers to any queries may be found on the Author FAQs, but if further support is needed Author Support can be contacted at cs-author@wiley.com.
All submissions to FEBS Open Bio should conform to standard ethical guidelines, details of which can be found on the website of the Committee on Publication Ethics (COPE).
See also Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals http://www.icmje.org
The work described in your article must have been carried out in accordance the ARRIVE Guidelines for reporting in vivo animal experiments ( http://www.nc3rs.org.uk/arrive-guidelines). Please include, in the Materials and Methods section, details of ethical guidelines (national or institutional) that were followed, and a description of any surgical procedures and peri-operative care.
Research involving human subjects or human tissues should comply with The Code of Ethics of the World Medical Association (Declaration of Helsinki) http://www.wma.net/en/30publications/10policies/b3/index.html. Please include a statement within the Materials and Methods section, indicating that informed consent has been obtained from each subject, and that the study methodologies have approval from the appropriate local ethics committee.
All authors are requested to disclose any actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations within three years of beginning the submitted work that could inappropriately influence, or be perceived to influence, their work.
Submission of an article implies that the work described:
-
Has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis or as an electronic preprint)
-
That it is not under consideration for publication elsewhere;
-
That its publication is approved by all authors and, tacitly or explicitly, by the responsible authorities where the work was carried out.
You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in: study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.
This journal is Open Access; all articles will be immediately and permanently free for everyone to read and download.
If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.
FEBS Open Bio offers corresponding authors the following license agreement:
Creative Commons Attribution License CC BY
To preview the terms and conditions of this open access agreement, please visit http://creativecommons.org/licenses/by/4.0/.
Manuscript preparation is crucial for the success of your article. Along with evaluating the technical quality of your results, the Editor and reviewers will judge your manuscript based on language, overall clarity and intelligibility. Poorly written articles, as well as spelling and grammatical mistakes, may ultimately lead to the rejection of your article, even though the scientific quality would warrant publication.For more informationabout language editing and copyediting services pre- and post-submission, visit http://wileyeditingservices.com/en/.
Any word processing software can be used to prepare your manuscript, provided that the files are saved in one of the common text file formats. The text should be in single-column format and the layout should be kept as simple as possible. Do not justify the text or hyphenate words at the ends of lines. However, do use bold face, italics, subscripts, superscripts, etc. Please use the 'spell-check' and 'grammar-check' functions of your word processor to avoid unnecessary errors. You may embed figures within the text for review purposes, but separate files for each figure will be required for publication.
• Title. This should state the subject of the manuscript clearly and concisely, with a maximum of 150 characters (including spaces). Titles should be optimized for discovery by search engines, see http://authorservices.wiley.com/bauthor/seo.asp. Avoid abbreviations and formulae where possible. The editors of FEBS Open Bio may edit titles for length and clarity.
• Authors’ names and affiliations. Affiliations (where the actual work was done) of all authors should be provided. The corresponding author should also provide a full postal address, telephone number, and an email address. If an author has moved since the work described in the article was done, or was visiting at the time, a 'Present address' (or 'Permanent address') may be indicated as a footnote to that author's name.
• Abstract. A concise (a maximum of 250 words) and factual abstract is required. The abstract should state the purpose of the research, the principal results and major conclusions. Non-standard or uncommon abbreviations should be avoided but, if essential, they must be defined at their first mention within the abstract. Include your keywords to optimize discovery by search engines.
• Keywords Please provide a maximum of 6 keywords that reflect the significant factors of the whole investigation. Keywords will be used for indexing and information retrieval. Only include abbreviations firmly established in the field.
• Abbreviations Please provide a list that defines all abbreviations used in the article that are not standard in the field. Ensure consistency of abbreviations throughout the article.
• Running heading Please provide a short title of not more than 50 characters including spaces.
State the objectives of the work and provide an adequate background, avoiding a detailed literature survey or a summary of the results.
Provide sufficient detail to allow the work to be reproduced. Methods already published should be indicated by a reference; only relevant modifications should be described. If experiments involving human or animal subjects or tissues have been carried out, then a statement about ethical approval must be included here; see Policies for further information.
Results should be clear and concise. Follow a logical flow for the experiments, which may not be in the same order as they were performed. Include all relevant data needed to support the conclusions.
The Discussion should explore the significance of the results, not repeat them. A combined Results and Discussion section is often appropriate. Avoid extensive citations and discussion of the published literature.
The main text should end with a short statement of the main conclusions of the study. This can be part of the Discussion or have a separate heading.
These should be collated in a separate section at the end of the article before the references and not on the title page.
-
List here those individuals who provided help during the research (e.g. provided reagents, corrected language, proof reading, etc.).
-
Identify all funding sources (including grant numbers where appropriate).
List here the specific contributions of each author (e.g. AA and BB conceived and designed the project, AA, CC and DD acquired the data, AA and CC analyzed and interpreted the data, AA and BB wrote the paper).
Where possible, you should cite the primary literature in which observations are first reported rather than reviews. There are no strict requirements on the number of references. Please ensure that every reference cited in the text is also present in the reference list and vice versa. Any references cited in the abstract must be given in full. Unpublished results and personal communications should not be included in the reference list, but may be mentioned in the text. Citation of a reference as 'in press' implies that the item has been accepted for publication. Please provide copies of any crucial ‘in press’ papers for reviewing purposes.
References should be numbered in the order in which they are cited within the text. Please use square brackets around reference numbers (e.g.[1,2].
Please style the reference list as follows:
1 Jensen, MK, Linemose, S, de Masi, F, Reimer, JJ, Nielsen, M, Perera, V, Workman, CT, Turck, F, Grant, MR, Mundy, J, Petersen M & Skriver, K (2013) ATAF1 transcription factor directly regulates abscisic acid biosynthetic gene NCED3 in Arabidopsis thaliana. FEBS Open Bio 3: 321–327
2 Capecchi, MR (2005) Gene targeting in mice: functional analysis of the mammalian genome for the twenty-first century. Nat Rev Genet 6: 507–512
3 Brinkman, EK, Chen, T, Amendola, M and van Steensel, B (2014) Easy quantitative assessment of genome editing by sequence trace decomposition. Nucleic Acids Res. 42: e168, doi: 10.1093/nar/gku936
4 Domagalska MA, Sarnowska E, Nagy F, Davis SJ (2010) Genetic Analyses of Interactions among Gibberellin, Abscisic Acid, and Brassinosteroids in the Control of Flowering Time in Arabidopsis thaliana. PLoS ONE 5: e14012. doi: 10.1371/journal.pone.0014012
5 Sambrook J, Fritsch EF & Maniatis T (1989) Molecular Cloning: A Laboratory Manual. Vol. 3, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
6 Langer T & Neupert W (1994) Chaperoning mitochondrial biogenesis. In The Biology of Heat Shock Proteins and Molecular Chaperones (Morimoto RI, Tissières A & Georgopoulos C, eds), pp. 53–83. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
The use of a tool such as EndNote or Reference Manager is recommended for reference management and formatting.
Ensure that the data presented in tables does not duplicate results described elsewhere in the article. Tables should be numbered in same order as they appear within the text. Place footnotes to tables below the table body and indicate them with superscript lowercase letters. If using a grid for tables, use only one grid for each table and not a grid for each row. If no grid is used, use tabs, not spaces, to align columns. Tables can be either included at the end of the main text or supplied as separate files.
Each figure should be submitted as a separate file. Please make sure that figure files are in an acceptable format (TIFF, EPS or PDF) and that the resolution is at least 300dpi. TIFF files may be saved using LZW compression. For further information on the preparation of artwork, please see http://authorservices.wiley.com/bauthor/illustration.asp
Figure captions (a title and a brief description of the illustration) should be included with the main text and not in figure files. Keep text in the illustrations themselves to a minimum and explain all symbols and abbreviations used in the caption.
FEBS Open Bio is published online only with no strict limit for the length of text or number of figures and tables. Thus, all methods, figures and tables should be included within the main text, and not as supplementary files. Supporting Information in the form of background datasets, sound clips and movies can also be published alongside your article. Captions for each supplementary file should be included at the end of the main text file. Supporting Information will not be copyedited. Please provide the data in one of our recommended file formats. More detailed instructions are available at http://exchanges.wiley.com/authors/supporting-information_336.html.
Authors should comply with available field-specific standards for the preparation and recording of data. We recommend authors refer to the Minimum Information for Biological and Biomedical Investigations (MIBBI) Portal for prescriptive checklists for reporting biological and biomedical research where applicable: http://www.biosharing.org/standards/mibbi.
FEBS Open Bio articles can contain hyperlinks to relevant external databases, giving readers one-click access to your data. To enable automatic hyperlinking, please ensure that the database identifiers are given in the format:
Database: XXXX
For example, for the entry 1BEN in the Protein Data Bank, use “PDB: 1BEN”.
Follow internationally accepted rules and conventions: use the international system of units (SI). If other quantities are mentioned, give their equivalent in SI. For further information, see IUPAC: Nomenclature of Organic Chemistry: http://www.iupac.org/
Present simple formulae in the line of normal text where possible and use the solidus (/) instead of a horizontal line for small fractional terms, e.g., X/Y. Variables are normally presented in italics. Powers of e are often more conveniently denoted by “exp”. Number consecutively any equations that have to be displayed separately from the text (if referred to explicitly in the text).
Please submit the names, addresses and e-mail addresses of up to six potential reviewers. These reviewers must be knowledgeable about the manuscript subject area; must not be from your own institution; at least two of the suggested reviewers should be from a country other than your own; and they should not have recent (less than four years) joint publications with any of the authors. You can also specify whom you would like to exclude from reviewing the manuscript. Note that the Editor retains the sole right to decide whether the suggested and excluded reviewers are used or not.
Make sure that you:
-
Include the names and email addresses of all authors, and the full postal address, and telephone number of the corresponding author
-
Include lists of keywords and abbreviations on the Title page
-
'Spell-check' and 'grammar-check' the manuscript
-
Upload all necessary files, including separate figure files at revision stage
-
Check that all the references cited in the text are included in the Reference list and vice versa
-
Include a statement naming the national legislation that has been followed, or institution/local body that approved the ethics of any experimentation involving humans or animals
-
Obtain permission for any use of copyrighted material from other sources (including the Web)
You will receive an email from Wiley giving you details of the publication process and who to contact if you have any queries post acceptance. You will also be given details of how to pay the article publication fee, which must be received before your article can be published.
After your license agreement form has been signed, a copy of your accepted article will be published online on Wiley Online Library as an Accepted Article. Please note that this version will not have been copyedited, and the PDF version will be the same as your submitted manuscript. Your article will then be typeset and you will receive proofs. The final, corrected version of your article will be posted online once we have received your corrections.
Early View
Early View articles are complete full-text articles published online in advance of their publication in an issue. Early View articles are the version of record and are complete and final. They have been fully reviewed, revised and edited for publication, and the authors’ final corrections have been incorporated. As they are in final form, no changes can be made after online publication. Early View articles are given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before it is allocated to an issue. After issue publication, the DOI remains valid and can continue to be used to cite and access the article.
A copy of this version will also be deposited in the repository PubMed Central. You may also post a copy of this final version in any repository or scholarly professional network (e.g. your institutional repository or ResearchGate).
We will do everything possible to get your article published quickly and accurately. FEBS Open Bio uses a web-based proof correction tool. Your article will be copyedited and typeset, and the corresponding author will then be invited to view the proofs online, via their Internet browser. Web-based proofing provides a faster and less error-prone process as you key in your own corrections, eliminating the potential introduction of errors. If preferred, you can still choose to annotate and upload your edits on the PDF version. All instructions for proofing will be given in the e-mail we send to authors, including alternative methods to the online version and PDF.
It is important to ensure that all corrections are sent back to us in one communication. Please check carefully before replying, as inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely your responsibility. Please upload all of your corrections within 48 hours. Note that Wiley may proceed with the publication of your article if no response is received.
FEBS Open Bio is keen to assist authors in publicizing their article. If you use social media to promote your article, please mention the journal Twitter account @FEBSOpenBio so that we can retweet your message.
Requests to add or remove an author, or to rearrange the author names, after acceptance of your paper must be sent to the Editorial Office and must include: (a) the reason the name should be added or removed, or the author names rearranged and (b) written confirmation (e-mail, fax, letter) from all authors, including those authors added or omitted, that they agree with the addition, removal or rearrangement. Any requests to add, delete, or rearrange author names after the article is published online will follow the same policies as noted above and result in a corrigendum.
Editorial Board
Executive Editor
Mary Purton
FEBS Open Bio Editorial Office, Cambridge, UK
Phone +44 1223 367011
Email Mary Purton
Senior Editors
Julio Celis
Institute of Cancer Biology, Copenhagen, Denmark
Stuart Ferguson
University of Oxford, Oxford, UK
Seamus Martin
Trinity College, Dublin, Ireland
Felix Wieland
Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
Associate Editors
Alberto Alape Giron
Universidad de Costa Rica, San José, Costa Rica
Edurne Berra Ramírez
CIC Biogune, DERIO, Spain
Antonio Castrillo Viguera
Instituto Investigaciones Biomedicas Alberto Sols, Madrid, Spain
Pierre Cosson
Université de Genève, Centre Medical Universitaire (CMU), Geneve 4-CH, Switzerland
Miguel De la Rosa
Consejo Superior de Investigaciones Científicas (CSIC), Sevilla, Spain
Takashi Gojobori
National Institute of Genetics, Mishima, Shizuoka, Japan
Jörg Kobarg
LNBio-Laboratório Nacional de Biociências, Campinas-SP, Brazil
Dietmar J. Manstein
Hannover Medical School (MHH), Hannover, Germany
Laszlo Nagy
University of Debrecen, Debrecen, Hungary
SBP Medical Discovery Institute, USA
Zhen-Ming Pei
Duke University, Durham, North Carolina, USA
Jan S. Potempa
Jagiellonian University Krakow, Kraków, Poland
Thomas Preiss
Australian National University, Canberra, Australian Capital Territory, Australia
Kristine Kleivi Sahlberg
Oslo University Hospital, Oslo, Norway
Cristiano Simone
Università degli Studi di Bari Aldo Moro, Bari, Italy
Sandro Sonnino
Università degli Studi di Milano, Segrate, Milan, Italy
Michael Sussman
University of Wisconsin at Madison, Madison, Wisconsin, USA
Tibor Vellai
Eötvös Lorand University, Budapest, Hungary
B.G. Vértessy
Institute of Enzymology, Budapest, Hungary
Rick Wansink
Radboudumc, Nijmegen, Netherlands
A. Wlodawer
Frederick, MD, USA
Koji Yamanaka
Nagoya University, Nagoya, Japan
Lei Yin
University of Michigan Medical School, Ann Arbor, Michigan, USA
| 
刊名字顺( Alphabetical List of Journals):
返回页首 